Asia Pacific Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Products (Enzymes, Chassis Organisms, Oligonucleotides, and Xeno-Nucleic Acids), Technology (Measurement & Modeling, Cloning & Sequencing, Genome Engineering, Gene Synthesis, Nanotechnology, and Others), and Application (Medical Applications, Industrial Applications, Food and Agriculture, Environmental Applications, and Others)

The APAC synthetic biology market is expected to grow from US$ 1,970.70 million in 2021 to US$ 7,343.06 million by 2028; it is estimated to grow at a CAGR of 20.7% from 2021 to 2028.

The synthetic biology—a branch of biotechnology—focusses on opportunities in the healthcare sector, involving drug delivery, protein therapeutics, biofuels, and food and agricultural product development. It provides opportunities for biotechnology entrepreneurs by enabling low-cost production. ThermoFisher Scientific capitalizes on flourishing business segments by targeting, innovating, and undertaking mergers and acquisitions.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC synthetic biology market. The APAC synthetic biology market is expected to grow at a notable CAGR during the forecast period.

APAC Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

APAC Synthetic Biology Market Segmentation  

The APAC synthetic biology market is analyzed based on products, technology, application, and country. Based on products, the market is segmented into enzymes, chassis organisms, oligonucleotides, and xeno-nucleic acids. The oligonucleotides segment dominated the market in 2020 and is expected to continue to grow at the fastest rate during the forecast period. Based on technology, the market is segmented into measurement & modeling, cloning & sequencing, genome engineering, gene synthesis, nanotechnology, and others. The gene synthesis segment dominated the market in 2020, while the genome engineering segment is expected to be fastest growing during the forecast period. Based on application, the market is segmented into medical applications, industrial applications, food and agriculture, environmental applications, and others. The medical applications segment dominated the market in 2020 and is expected to garner the highest CAGR during the forecast period. The APAC synthetic biology market is segmented into China, Japan, India, South Korea, Australia, and Rest of APAC.

Agilent Technologies, Inc.; Amyris; Codexis; Genscript Biotech corporation; Integrated DNA Technologies; Merck KGaA; New England Biolabs; Novozymes A/S; Thermo Fisher Scientific; and Twist Bioscience are among the leading companies in the APAC synthetic biology market.

1. Agilent Technologies, Inc.
2. Amyris
3. Codexis
4. Genscript Biotech corporation
5. Integrated DNA Technologies
6. Merck KGaA
7. New England Biolabs
8. Novozymes A/S
9. Thermo Fisher Scientific
10. Twist Bioscience

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC synthetic biology market.       
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the APAC synthetic biology market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the synthetic biology market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution